VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,676 | -63.7% | 2,634 | -5.3% | 0.00% | – |
| Q2 2023 | $67,892 | +23.9% | 2,780 | +18.5% | 0.00% | – |
| Q1 2023 | $54,778 | -15.9% | 2,346 | -8.6% | 0.00% | – |
| Q4 2022 | $65,164 | -10.7% | 2,566 | -31.7% | 0.00% | – |
| Q3 2022 | $73,000 | +128.1% | 3,758 | +198.7% | 0.00% | – |
| Q2 2022 | $32,000 | -87.8% | 1,258 | -84.5% | 0.00% | -100.0% |
| Q1 2022 | $262,000 | -34.0% | 8,106 | -17.5% | 0.00% | 0.0% |
| Q4 2021 | $397,000 | +15.7% | 9,826 | +9.4% | 0.00% | 0.0% |
| Q3 2021 | $343,000 | +3.9% | 8,980 | +20.8% | 0.00% | 0.0% |
| Q2 2021 | $330,000 | -11.1% | 7,431 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $371,000 | -29.1% | 7,409 | -62.0% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | +868.5% | 19,510 | +1160.3% | 0.00% | – |
| Q3 2020 | $54,000 | -53.8% | 1,548 | -46.1% | 0.00% | – |
| Q2 2020 | $117,000 | +21.9% | 2,870 | +2.5% | 0.00% | – |
| Q1 2020 | $96,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |